Bottom line
Is EUDG a good fund? The bottom line
EUDG is an actively managed dividend & equity income ETF from WisdomTree.
Annual fees run 0.58% — about $58 a year on every $10,000 invested, cheaper than 67% of dividend & equity income funds we track.
It returned +28.4% over one year, +7.1% a year over five years, +7.9% a year over ten (as of Dec 31, 2025, per its prospectus).
With $67.5 million in net assets and 230 holdings, its largest position is Novartis Ag (5.1%) and the top 10 make up 35.4% of the portfolio.
What stands out
- Broadly diversified (230 holdings)
What to watch
- 5-year return in the bottom quarter of its category
Updated Nov 19, 2026
What EUDG invests in
The WisdomTree Europe Quality Dividend Growth Fund (the Fund) seeks to track the price and yield performance, before fees and expenses, of the WisdomTree Europe Quality Dividend Growth Index (the Index).
The Fund employs a passive management or indexing investment approach designed to track the performance of the Index. The Fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the Index whose risk, return, and other characteristics resemble the risk, return, and other characteristics of the Index as a whole. The Fund invests, under normal circumstances, at least 80% of its net assets, plus any borrowings for investment purposes, in constituents of the Index and/or investments that have economic characteristics that are substantially similar to the economic characteristics of such constituents. WisdomTree, Inc. (WisdomTree), the Index Provider and parent company of the Funds investment adviser, WisdomTree Asset Management, Inc. (WisdomTree Asset Management or the Adviser), designed…
From the fund's prospectus (filed Jul 29, 2026).
EUDG performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| EUDG | +28.4% | +7.1% | +7.9% |
| Dividend & Equity Income median | +14.6% | +10.1% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What EUDG costs
On a $10,000 investment, EUDG's 0.58% expense ratio costs about $58 a year. The prospectus estimates $726 in total costs over 10 years (assuming 5% annual returns). The median dividend & equity income fund charges 0.74%.
EUDG top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Novartis Ag NOVN | 5.09% |
| 2 | Nestle' Sa/ag NESN | 4.89% |
| 3 | Roche Holding Ag ROP | 4.37% |
| 4 | Industria De Diseno Textil Sa ITX | 3.38% |
| 5 | Lvmh Moet Hennessy Louis Vuitton Se MC | 3.32% |
| 6 | Banco Bilbao Vizcaya Argentaria Sa BBVA | 3.32% |
| 7 | Asml Holding Nv ASML | 2.98% |
| 8 | Bp Plc BP/ | 2.81% |
| 9 | Ing Groep Nv INGA | 2.67% |
| 10 | Astrazeneca Plc AZN | 2.61% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 35.4% of the fund. See all top 25 holdings and asset mix →